China Animal Husbandry divests Zhongpu Biopharmaceutical stake, ends consolidation

China Animal Husbandry Industry Co., Ltd. (China Animal Husbandry) announced progress on its decision to waive its preemptive right to acquire a 4.04% equity stake in Zhongpu Biopharmaceutical Co., Ltd. (Zhongpu Biopharmaceutical). This stake, previously held by CITIC Agriculture Technology Co., Ltd., has been transferred to Pulike Biological Engineering Co., Ltd. (Pulike).

The transaction was confirmed on December 15, 2025, with China Animal Husbandry receiving a "Property Rights Transaction Certificate (Class A1 - Listed)" from the Shanghai United Assets and Equity Exchange. The transfer was conducted via an agreement at a price of 17,514,300 yuan, paid in a single installment.

Following the completion of this equity transfer, China Animal Husbandry will retain a 48.99% ownership in Zhongpu Biopharmaceutical. As a result, Zhongpu Biopharmaceutical will no longer be classified as a controlled subsidiary, and its financial data will no longer be consolidated into China Animal Husbandry's financial statements. The company states that this transaction will not harm the company or its shareholders, and its impact on the 2025 financial results will be reflected in the 2025 annual report.